Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment

Sa1052 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1. The PAN Study

Gastroenterology ◽

10.1016/s0016-5085(13)63650-1 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-983

Author(s):

Gero Moog ◽

Stefan Mauss ◽

Dietrich Hueppe ◽

Ulrich Spengler ◽

Eckart Schott ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Real Life ◽

Genotype 1 ◽

Life Conditions ◽

Sa1041 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study

Gastroenterology ◽

10.1016/s0016-5085(13)63639-2 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-980 ◽

Cited By ~ 1

Author(s):

Gero Moog ◽

Stefan Mauss ◽

Dietrich Hueppe ◽

Ulrich Spengler ◽

Eckart Schott ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Real Life ◽

Genotype 1 ◽

Life Conditions ◽

Sa1050 Efficacy of Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1: The PAN Study

Gastroenterology ◽

10.1016/s0016-5085(13)63648-3 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-982

Author(s):

Gero Moog ◽

Stefan Mauss ◽

Dietrich Hueppe ◽

Ulrich Spengler ◽

Eckart Schott ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Real Life ◽

Genotype 1 ◽

Life Conditions ◽

1001 INTERIM ANALYSIS FROM TRIC-1 A STUDY OF METFORMIN WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT NAIVE GENOTYPE 1 CHRONIC HEPATITIS C WITH INSULIN RESISTANCE

10.1016/s0168-8278(08)61003-x ◽

2008 ◽

Vol 48 ◽

pp. S375 ◽

Cited By ~ 4

Author(s):

M. Romero-Gomez ◽

M. Diago ◽

R.J. Andrade ◽

J.L. Calleja ◽

J. Salmeron ◽

...

Keyword(s):

Insulin Resistance ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interim Analysis ◽

Genotype 1 ◽

Treatment Naïve ◽

Treatment of chronic hepatitis C Genotype 1 (G1) infection with boceprevir (Victrelis®) in the German real-life setting: First results for treatment-naïve patients from the Novus observational study

Zeitschrift für Gastroenterologie ◽

10.1055/s-0033-1352957 ◽

2013 ◽

Vol 51 (08) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Observational Study ◽

Chronic Hepatitis C ◽

Real Life ◽

Genotype 1 ◽

Real Life Setting ◽

First Results ◽

Treatment Naïve

Development of autoantibodies against “rings and rods”-associated IMPDH2 in chronic hepatitis C genotype 1 infection during protease inhibitor based triple therapy in a “real life” cohort

Zeitschrift für Gastroenterologie ◽

10.1055/s-0036-1597391 ◽

2016 ◽

Vol 54 (12) ◽

pp. 1343-1404

Author(s):

W Dammermann ◽

S Polywka ◽

I Dettmann ◽

S Mindorf ◽

L Komorowski ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Protease Inhibitor ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Real Life ◽

Genotype 1

404 DOSE REDUCTION OF PEGINTERFERON ALFA-2A (PEG) IN COMBINATION WITH RIBAVIRIN (RBV) IN CHRONIC HEPATITIS C (CHC) PATIENTS: IMPACT ON VIROLOGICAL RESPONSE UNDER REAL LIFE CONDITIONS

10.1016/s0168-8278(11)60406-6 ◽

2011 ◽

Vol 54 ◽

pp. S162

Author(s):

K. Boeker ◽

S. Mauss ◽

D. Hueppe ◽

M. Schuchmann ◽

W. Schiffelholz ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Dose Reduction ◽

Chronic Hepatitis C ◽

Virological Response ◽

Real Life ◽

Life Conditions ◽

1163 A PHASE 2A STUDY OF BMS-791325, AN NS5B POLYMERASE INHIBITOR, WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

10.1016/s0168-8278(12)61175-1 ◽

2012 ◽

Vol 56 ◽

pp. S460 ◽

Cited By ~ 4

Author(s):

H. Tatum ◽

P. Thuluvath ◽

E. Lawitz ◽

C.T. Martorell ◽

M. Demicco ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Hepatitis C Infection ◽

Ns5b Polymerase Inhibitor ◽

Treatment Naïve ◽

Polymerase Inhibitor ◽

Peginterferon Alfa ◽

Ns5b Polymerase

793 REAL-LIFE DATA OF TELAPREVIR-BASED TRIPLE-THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C GT1 IN GERMANY – AN INTERIM ANALYSIS

10.1016/s0168-8278(13)60795-3 ◽

2013 ◽

Vol 58 ◽

pp. S324 ◽

Cited By ~ 2

Author(s):

T. Berg ◽

P. Buggisch ◽

D. Hueppe ◽

H. Wedemeyer ◽

M. Schuier ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Interim Analysis ◽

Real Life ◽

Life Data ◽

Real Life Data

M1794 Efficacy and Tolerability of Peginterferon Alfa-2a (40KD) (PEG) and Ribavirin (RBV) in Genotype 5 and 6 Patients with Chronic Hepatitis C Under Real Life Conditions

Gastroenterology ◽

10.1016/s0016-5085(09)63868-3 ◽

2009 ◽

Vol 136 (5) ◽

pp. A-839-A-840

Author(s):

Dietrich Hueppe ◽

Elmar Zehnter ◽

Stefan Mauss ◽

Stephan Kaiser ◽

Andreas Schober ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real Life ◽

Life Conditions ◽

Genotype 5 ◽